Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Nov 07, 2024

Axonics Reports Third Quarter 2024 Financial Results

Sep 26, 2024

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

Sep 18, 2024

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

Aug 01, 2024

Axonics Reports Second Quarter 2024 Financial Results

May 16, 2024

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

Apr 30, 2024

Axonics Reports First Quarter 2024 Financial Results

Mar 22, 2024

Axonics Stockholders Approve Merger Agreement with Boston Scientific

Mar 21, 2024

Axonics Provides Update on Inter Partes Review Proceedings

Mar 14, 2024

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Feb 29, 2024

Axonics Responds to ITC Action by Medtronic

Pagination

Current page 1
Page 2
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

© 2020-2024 Axonics, Inc.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap